1. What the clinical pages are for
Convenio de Farmacia offers educational, guidance-only tools for healthcare professionals (pharmacists, pharmacy technicians, doctors, nurses) and for patients who want to understand their own treatment. We are NOT a prescribing system, an electronic dispensing system or a telemedicine service.
Every clinical page on this site — the drug reference, paediatric dosing, interactions, pregnancy and breastfeeding, and the rest — exists to help you check, remember or screen information the professional already knows. Not to replace their judgement.
2. The official sources we use
The content is always built on official sources. We do not copy content — we link to the source:
- AEMPS — CIMA (cima.aemps.es): the official Summary of Product Characteristics for every medicine marketed in Spain. Our main and highest-priority source.
- AEMPS safety notices and quality alerts: aemps.gob.es
- NotificaRAM (notificaram.es): Spain's official pharmacovigilance system.
- Pediamécum (Spanish Association of Paediatrics): paediatric dosing.
- e-lactancia (APILAM): drug compatibility with breastfeeding.
- BOT-PLUS (Spanish General Pharmaceutical Council): professional drug database.
- SEFAC: community pharmacy practice guidance.
- Spanish Ministry of Health: the national immunisation schedule and regulation.
- Spanish and European clinical guidelines (semFYC, SEC, ESC and others) where relevant.
This list is mostly Spanish and European, and that matters. Licensed indications, available strengths and brand names differ between countries; dosing and mechanism generally do not. Where the two diverge, the source that governs is the product information approved by the regulator in your own country — the MHRA in the UK, the FDA in the US, the EMA and national agencies across the EU.
When a tool has to generate information on the fly — a record for a drug that is not preloaded — we use artificial intelligence with a system prompt that requires the model to work from these same sources and to remind you to verify against the official product information.
3. How we use AI
There are three kinds of information on this site, depending on where it came from:
The AI layer uses Google's Gemini models with a restrictive prompt that:
- Limits answers to pharmaceutical and clinical topics.
- Explicitly declines questions outside that scope (employment, politics, sport and so on).
- Requires the model to cite its source and to flag the need to verify.
- Caches identical answers for 30 days, to reduce variability and cost.
Even so, the AI can be wrong. Any dose, interaction or recommendation written by AI must be checked against the official product information before any clinical decision.
4. Limitation of liability
By using the clinical tools on this site, you accept and acknowledge that:
- The information is for guidance and education. It does not replace a consultation with a qualified healthcare professional.
- The final clinical judgement always rests with the pharmacist, doctor or nurse responsible for the patient.
- Before making decisions about medication, dosing, interactions or safety, you must check the official product information — in Spain at CIMA (AEMPS), and elsewhere with your own regulator.
- conveniodefarmacia.com accepts no liability for decisions taken solely on the basis of what is published here, without professional verification.
- For a suspected side effect, report it through your national pharmacovigilance scheme: NotificaRAM in Spain, the Yellow Card Scheme in the UK, and the equivalent in your own country.
- In an emergency — suspected overdose, anaphylaxis, bleeding — call your local emergency number without delay (112 across the EU, 999 in the UK, 911 in the US).
5. Keeping the content up to date
The curated content is reviewed regularly against the latest version of the Spanish product information and current safety alerts. Even so, clinical information moves: new alerts, withdrawals or changes to a product's licence can happen at any time. The official source always prevails.
If you spot an error or something out of date, write to us through our contact form and we will fix it as soon as we can.
6. Personal data and the GDPR
Using the public drug reference, search tools and calculators is anonymous: no account is needed and no identifying data is stored. AI queries are recorded in a technical log with a hashed IP address, for statistics and abuse prevention, as set out in the privacy policy.
The advanced features do require an account, and follow the GDPR safeguards described in that privacy policy.
7. Our ethical and professional commitment
This platform was built and is maintained by a pharmacist registered in Spain. The content follows the professional and ethical principles of pharmacy practice:
- It does not encourage irresponsible self-medication. For minor ailments we screen and point to the doctor where that is the right answer.
- It does not replace an in-person consultation with your own pharmacist.
- It has no hidden commercial purpose: we do not recommend particular brands for financial reasons and we take no payment from manufacturers.
- It does not publish dangerous content: the system actively refuses requests about recreational dosing, self-harm, or risky self-medication.
8. Contact
To report an error, ask a regulatory question or exercise your GDPR rights:
- Our contact form (the form is in Spanish; you are welcome to write in English).
- To report a side effect officially, use your national scheme — NotificaRAM in Spain, the Yellow Card Scheme in the UK — not this form.
- In an emergency: your local emergency number (112 in the EU, 999 in the UK, 911 in the US).
Last updated: 21 August 2026.